Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
VERDESIAN LIFE SCIENCES U.S., LLC has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 examiners across 3 art units, indicating separate examiner assignments with some concentration in the technical groups.
HOLT, ANDRIAE M is the listed busiest examiner, with 1 pending matter. Counsel should coordinate portfolio-wide technical positions while managing each response according to its assigned examiner and art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLT, ANDRIAE M | 1 | 49.5% | +23.0% |
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 53.1% | +20.6% |
| FAY, ZOHREH ALEMZADEH | 1 | 52.1% | -6.2% |
| LANGEL, WAYNE A | 1 | 78.4% | +23.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18918833 | MYCORRIHIZAL COMPOSITIONS AND RELATED METHODS OF MANUFACTURE AND USE | HOLT, ANDRIAE M | — |
| 18691166 | PYROGLUTAMIC ACID AS AN HERBICIDE SAFENER AND METHODS OF USE THEREOF | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| 18690931 | CORROSION INHIBITORS FOR NITROGEN INHIBITOR FORMULATION | FAY, ZOHREH ALEMZADEH | — |
| 18690368 | CORROSION INHIBITORS FOR NITRAPYRIN CONTAINING AGRICULTURAL FORMULATIONS | LANGEL, WAYNE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18918833 | MYCORRIHIZAL COMPOSITIONS AND RELATED METHODS OF MANUFACTURE AND USE | HOLT, ANDRIAE M | — |
| 18691166 | PYROGLUTAMIC ACID AS AN HERBICIDE SAFENER AND METHODS OF USE THEREOF | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| 18690368 | CORROSION INHIBITORS FOR NITRAPYRIN CONTAINING AGRICULTURAL FORMULATIONS | LANGEL, WAYNE A | — |
| Art Unit | Apps |
|---|---|
| 1617 | 2 |
| 1614 | 1 |
| 1736 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18918833 | MYCORRIHIZAL COMPOSITIONS AND RELATED METHODS OF MANUFACTURE AND USE | HOLT, ANDRIAE M | 1614 | §102§103 | Non-Final OA | — | Pending | Oct 17, 2024 |
| 18691166 | PYROGLUTAMIC ACID AS AN HERBICIDE SAFENER AND METHODS OF USE THEREOF | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §103§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18690931 | CORROSION INHIBITORS FOR NITROGEN INHIBITOR FORMULATION | FAY, ZOHREH ALEMZADEH | 1617 | §103§112 | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18690368 | CORROSION INHIBITORS FOR NITRAPYRIN CONTAINING AGRICULTURAL FORMULATIONS | LANGEL, WAYNE A | 1736 | §102§103§112 | Non-Final OA | — | Pending | Mar 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVERDESIAN LIFE SCIENCES U.S., LLC has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Andriae M Holt has the most, with 1 of VERDESIAN LIFE SCIENCES U.S., LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
